Andrew Turitz is EVP, CORPORATE DEVELOPMENT of Teladoc Health, Inc.. Currently has a direct ownership of 37,659 shares of TDOC, which is worth approximately $346,839. The most recent transaction as insider was on Jun 03, 2024, when has been sold 1,627 shares (Common Stock) at a price of $11.16 per share, resulting in proceeds of $18,157. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 37.7K
11.48% 3M change
58.45% 12M change
Total Value Held $346,839

Andrew Turitz Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 03 2024
SELL
Open market or private sale
$18,157 $11.16 p/Share
1,627 Reduced 4.14%
37,659 Common Stock
May 31 2024
BUY
Exercise of conversion of derivative security
-
5,504 Added 12.29%
39,286 Common Stock
Mar 05 2024
SELL
Open market or private sale
$82,050 $14.53 p/Share
5,647 Reduced 14.32%
33,782 Common Stock
Mar 04 2024
SELL
Open market or private sale
$89,878 $14.52 p/Share
6,190 Reduced 13.57%
39,429 Common Stock
Mar 01 2024
SELL
Open market or private sale
$7,153 $15.06 p/Share
475 Reduced 1.85%
25,193 Common Stock
Mar 01 2024
BUY
Exercise of conversion of derivative security
-
20,426 Added 30.93%
45,619 Common Stock
Dec 04 2023
SELL
Open market or private sale
$7,503 $18.9 p/Share
397 Reduced 1.52%
25,668 Common Stock
Dec 01 2023
BUY
Exercise of conversion of derivative security
-
1,347 Added 4.91%
26,065 Common Stock
Sep 05 2023
SELL
Open market or private sale
$9,064 $22.89 p/Share
396 Reduced 1.58%
24,718 Common Stock
Sep 01 2023
BUY
Exercise of conversion of derivative security
-
1,347 Added 5.09%
25,114 Common Stock
Jun 02 2023
SELL
Open market or private sale
$9,410 $24.38 p/Share
386 Reduced 1.6%
23,767 Common Stock
Jun 01 2023
BUY
Exercise of conversion of derivative security
-
1,347 Added 5.28%
24,153 Common Stock
Mar 03 2023
SELL
Open market or private sale
$46,508 $25.91 p/Share
1,795 Reduced 7.3%
22,806 Common Stock
Mar 02 2023
SELL
Open market or private sale
$45,673 $25.36 p/Share
1,801 Reduced 8.92%
18,382 Common Stock
Mar 02 2023
BUY
Exercise of conversion of derivative security
-
6,219 Added 20.18%
24,601 Common Stock
Mar 01 2023
BUY
Exercise of conversion of derivative security
-
5,389 Added 21.07%
20,183 Common Stock
Mar 07 2022
SELL
Open market or private sale
$89,031 $66.74 p/Share
1,334 Reduced 8.27%
14,794 Common Stock
Mar 04 2022
BUY
Exercise of conversion of derivative security
-
4,541 Added 21.97%
16,128 Common Stock
Mar 03 2022
SELL
Open market or private sale
$123,201 $70.24 p/Share
1,754 Reduced 13.15%
11,587 Common Stock
Mar 02 2022
BUY
Exercise of conversion of derivative security
-
5,785 Added 30.25%
13,341 Common Stock
Mar 08 2021
SELL
Open market or private sale
$224,463 $188.15 p/Share
1,193 Reduced 13.64%
7,556 Common Stock
Mar 05 2021
SELL
Open market or private sale
$502,968 $188.66 p/Share
2,666 Reduced 23.36%
8,749 Common Stock
Mar 04 2021
SELL
Open market or private sale
$375,006 $200.86 p/Share
1,867 Reduced 21.36%
6,874 Common Stock
Mar 04 2021
BUY
Exercise of conversion of derivative security
-
4,541 Added 28.46%
11,415 Common Stock
Mar 03 2021
SELL
Open market or private sale
$420,144 $210.81 p/Share
1,993 Reduced 22.45%
6,885 Common Stock
AT

Andrew Turitz

EVP, CORPORATE DEVELOPMENT
Purchase, NY

Track Institutional and Insider Activities on TDOC

Follow Teladoc Health, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TDOC shares.

Notify only if

Insider Trading

Get notified when an Teladoc Health, Inc. insider buys or sells TDOC shares.

Notify only if

News

Receive news related to Teladoc Health, Inc.

Track Activities on TDOC